Anthem Biosciences IPO Listing Today: 67x Subscription, Strong GMP; What to Expect?

Anthem Biosciences IPO Listing Today: 67x Subscription, Strong GMP; What to Expect?

The highly anticipated Anthem Biosciences IPO is set to list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) today at 10:00 am. The initial public offering (IPO) saw an impressive 67.42 times subscription, indicating strong demand from investors.

The IPO, which is an offer-for-sale (OFS), has raised Rs 1,016 crore from anchor investors ahead of its initial share-sale opening for public subscription. The company will not receive any funds from the issue, and the proceeds will go to the selling shareholders.

How to Check Allotment Status?

Investors can check their allotment status on the Kfin Technologies’ portal or the BSE website. Here’s a step-by-step guide:

  1. Visit the Registrar’s Website: Go to https://ipostatus.kfintech.com/.
  2. Select the IPO: From the dropdown menu, choose ‘Anthem Biosciences Limited’. Note that the IPO name will only appear once the allotment is finalized.
  3. Choose an Identification Mode: Select one of the following options to check your status:
    • Enter Details: Input the details corresponding to the selected mode (e.g., your PAN, application number, or Demat account details).
    • Complete CAPTCHA: Fill in the CAPTCHA for security verification and click ‘Submit’ to view your allotment status.

    Alternatively, you can also check the allotment status on the BSE website:

    1. Visit the BSE IPO Page: Go to https://www.bseindia.com/investors/appli_check.aspx.
    2. Select Issue Type: Choose ‘Equity’ as the issue type.
    3. Select IPO: From the dropdown menu, select ‘Anthem Biosciences Limited’.
    4. Enter Details: Provide your Application Number or PAN.
    5. Complete CAPTCHA: Tick the ‘I’m not a robot’ CAPTCHA and click ‘Search’ to view your allotment status.

    About Anthem Biosciences

    Anthem Biosciences is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development, and manufacturing.

    The company also manufactures and sells complex specialized fermentation-based Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars.

    Frequently Asked Questions

    Q: What is the Anthem Biosciences IPO listing date? A: The IPO is listing today at 10:00 am on BSE and NSE.

    Q: How to check allotment status? A: Investors can check their allotment status on the Kfin Technologies’ portal or the BSE website.

    Q: What is the Anthem Biosciences IPO size? A: The IPO has raised Rs 1,016 crore from anchor investors.

    Q: Will the company receive any funds from the issue? A: No, the company will not receive any funds from the issue, and the proceeds will go to the selling shareholders.

    Sreenivasulu Malkari

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top